Stock LIFE LIFECARE
Add to a list
To use this feature you must be a member
Log inSign up

Financials Lifecare

Equities

LIFE

NO0010591191

Biotechnology & Medical Research

Market Closed - Oslo Bors
Other stock markets
 10:45:00 2024-04-26 am EDT 		5-day change 1st Jan Change
2.965 NOK -12.92% Intraday chart for Lifecare -20.62% -33.52%
Apr. 26 Lifecare to Take Majority Stake in Medical Technology Company RemovAid MT
Apr. 26 Lifecare Seeks Fresh Capital from Rights Offering MT

Valuation

Fiscal Period: December 2023 2024 2025 2026
Capitalization 1 601.5 399.9 - -
Enterprise Value (EV) 1 601.5 327 399.9 399.9
P/E ratio - - - -
Yield - - - -
Capitalization / Revenue 52 x 46 x 5.67 x 1.51 x
EV / Revenue 52 x 37.6 x 5.67 x 1.51 x
EV / EBITDA -18.2 x -5.24 x -7.28 x 10.5 x
EV / FCF -15.4 x -5.19 x -3.77 x -
FCF Yield -6.47% -19.3% -26.5% -
Price to Book - - - -
Nbr of stocks (in thousands) 134,866 134,866 - -
Reference price 2 4.460 2.965 2.965 2.965
Announcement Date 2/27/24 - - -
1NOK in Million2NOK
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: December 2023 2024 2025 2026
Net sales 1 11.56 8.7 70.5 264.2
EBITDA 1 -33.01 -62.4 -54.9 38.2
EBIT 1 -35.88 -66.6 -60.3 24.9
Operating Margin -310.4% -765.52% -85.53% 9.42%
Earnings before Tax (EBT) - - - -
Net income - - - -
Net margin - - - -
EPS - - - -
Free Cash Flow 1 -38.94 -63 -106 -
FCF margin -336.82% -724.14% -150.35% -
FCF Conversion (EBITDA) - - - -
FCF Conversion (Net income) - - - -
Dividend per Share - - - -
Announcement Date 2/27/24 - - -
1NOK in Million
Estimates

Income Statement Evolution (Quarterly data)

Fiscal Period: December 2023 Q2 2023 Q3 2023 Q4
Net sales 1 - 2.568 5.152
EBITDA 1 - -6.055 -14.54
EBIT 1 - -6.658 -15.32
Operating Margin - -259.32% -297.27%
Earnings before Tax (EBT) - - -
Net income -8.165 -7.029 -
Net margin - -273.75% -
EPS -0.0690 - -
Dividend per Share - - -
Announcement Date 8/23/23 11/14/23 2/27/24
1NOK in Million
Estimates

Balance Sheet Analysis

Fiscal Period: December 2023 2024 2025 2026
Net Debt 1 - - - -
Net Cash position 1 - 72.9 - -
Leverage (Debt/EBITDA) - - - -
Free Cash Flow 1 -38.9 -63 -106 -
ROE (net income / shareholders' equity) - - - -
ROA (Net income/ Total Assets) - - - -
Assets - - - -
Book Value Per Share - - - -
Cash Flow per Share - - - -
Capex 1 0.82 15 40 -
Capex / Sales 7.13% 172.41% 56.74% -
Announcement Date 2/27/24 - - -
1NOK in Million
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Change in Enterprise Value/EBITDA

Chiffre d''affaires - Rate of surprise

Company calendar

Sector Other Biotechnology & Medical Research

1st Jan change Capi.
LIFECARE Stock Lifecare
-33.52% 36.21M
IQVIA HOLDINGS INC. Stock Iqvia Holdings Inc.
+1.51% 42.75B
LONZA GROUP AG Stock Lonza Group AG
+49.22% 41.61B
MODERNA, INC. Stock Moderna, Inc.
+8.57% 41.34B
CELLTRION, INC. Stock Celltrion, Inc.
-12.36% 26.59B
ICON PUBLIC LIMITED COMPANY Stock ICON Public Limited Company
+8.92% 25.49B
ALNYLAM PHARMACEUTICALS, INC. Stock Alnylam Pharmaceuticals, Inc.
-25.13% 18.12B
MEDPACE HOLDINGS, INC. Stock Medpace Holdings, Inc.
+29.17% 12.24B
CHARLES RIVER LABORATORIES INTERNATIONAL, INC. Stock Charles River Laboratories International, Inc.
-3.12% 11.76B
UNITED THERAPEUTICS CORPORATION Stock United Therapeutics Corporation
+6.35% 11B
Other Biotechnology & Medical Research
  1. Stock Market
  2. Equities
  3. LIFE Stock
  4. Financials Lifecare